About NeuWave
NeuWave is a Healthcare company based in Madison (United States) founded in 2004, and was acquired by Quantum Surgical in February 2026. Microwave ablation systems for soft tissue and cancer are developed. NeuWave has raised $52.68 million across 9 funding rounds from investors including HHS, Quantum Surgical and HIG BioHealth Partners. Its focus areas include Services for Healthcare Providers, BPO and Medical Equipment Management. Its legal entity is ETHICON US, LLC. Its competitors include KLOwen, The InterMed Group and Panorama Eyecare; 2 of its 3 listed competitors have raised funding.
Company details
NeuWave Medical has developed the Certus 140 Microwave Ablation System for soft tissue and cancerous tissue ablation including lung, liver, kidney cancers. Also provides probes and surgical tools to support the ablation procedure. Its a hand held device with flexible power delivery settings. They have received 510(k) clearance for their Certus 140TM 2.45 GHz Ablation System. In March 2016, NeuWave Medical was acquired by Ethicon, a division of Johnson Johnson.
- Headquarters Madison, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website neuwave.com
- Social LinkedIn Facebook
- Acquired by Ethicon (Mar 2016)
- Legal Name Ethicon Us, Llc
- Total Equity Funding$52.68M (USD)
in 9 rounds
- Latest Funding Round$25M (USD), Series C
May 2015
- InvestorsHHS
& 7 more
- Acquired by
Funding Insights of NeuWave
NeuWave has successfully raised a total of $52.68M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $25 million completed in May 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $52.68M
- Total Rounds 9
- Last Round Series C — $25M
- First Round $4.5M
(Feb 2008)
- Investors Count 6
All 9 funding rounds of NeuWave with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2015 | $25M | Series C | – | – | |
| Sep 2014 | $4.76M | Debt – Conventional | – | – | – |
| Sep 2012 | $14M | Series B | – | – | |
| Apr 2011 | $8.18M | Series A | – | – | – |
| Sep 2010 | $2M | Grant | – | – | |
| Nov 2009 | $2M | Grant | – | – | – |
| May 2009 | $999,999 | Series A | – | – | – |
| Sep 2008 | $2M | Grant | – | – | |
| Feb 2008 | $4.5M | Series A | – | – |
8 investors in total: 8 institutional.
Investors in NeuWave
NeuWave has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS, Quantum Surgical and HIG BioHealth Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999. | versantventures.com | |||
Multiple sectors focused seed & early stage VC firm investing in the US, Europe & Asia | ventureinvestors.com | Madison, United States | ||
| higbio.com | ||||
| swib.state.wi.us | ||||
Research innovations are supported and commercialized by WARF. | warf.org | Madison, United States | ||
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
Specializes in surgical sutures and wound closure devices. | 1886 | ethicon.com | Cincinnati, United States | |
Minimally invasive surgical robotics for tumor ablation therapies are provided. | 2010 | quantumsurgical.com | Montpellier, France |
Investor details for NeuWave
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of NeuWave
5 dated milestones of NeuWave across 22 years, from founding to its latest funding, stage changes and deals.
- Founded NeuWave is founded.
- Funding First funding round of $4.5M.
- Funding Latest funding round, Series C, of $25.0M.
- Exit Acquired by Ethicon.
- Exit Acquired by Quantum Surgical.
Competitors of NeuWave
NeuWave has 3 listed competitors in our database, 2 of them funded. They include KLOwen, The InterMed Group and Panorama Eyecare.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| klowenortho.com | 2019 | Richardson, United States | $30.09M | Digital tools for orthodontists are provided by KLOwen. | ||
| intermed1.com | 1996 | Alachua, United States | 127 | Healthcare technology management services and equipment are provided. | ||
| panoramaeyecare.com | 2021 | Fort Collins, United States | $150M | Physician-led management services for eye care professionals are provided. |
Detailed competitors of NeuWave
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Healthcare Provider Support Services
3 companies that operate in the same segment as NeuWave (Healthcare Provider Support Services) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of self funded health plan | 2017 | New York, New York, United States | USD 224 M | 212 | ||
Provider of AI solutions for clinical, operational, and business outcomes | 2005 | Princeton, New Jersey, United States | USD 1.13 B | USD 465.22 M | 5,442 | |
AMN Healthcare is recognized as a leading healthcare staffing provider. | 1985 | San Diego, California, United States | USD 2.73 B | 2,970 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Neuwave
Complete news archive for NeuWave
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NeuWave
NeuWave was founded in 2004 and raised its 1st funding round 4 years after it was founded.
NeuWave is headquartered in Madison, United States. It is registered at Madison, Wisconsin, United States.
NeuWave is a funded company, having raised a total of $52.68M across 9 funding rounds to date. The company's 1st funding round was a Series A of $4.5M, raised on Feb 2008.
NeuWave Medical has developed the Certus 140 Microwave Ablation System for soft tissue and cancerous tissue ablation including lung, liver, kidney cancers. Also provides probes and surgical tools to support the ablation procedure. Its a hand held device with flexible power delivery settings. They have received 510(k) clearance for their Certus 140TM 2.45 GHz Ablation System. In March 2016, NeuWave Medical was acquired by Ethicon, a division of Johnson Johnson.
NeuWave's top competitors include KLOwen, The InterMed Group and Panorama Eyecare.
NeuWave has 8 investors. Key investors include HHS, Quantum Surgical, HIG BioHealth Partners, Versant Ventures, and Venture Investors.
NeuWave operates through Ethicon Us, Llc.
Yes. NeuWave was acquired by Ethicon in March 2016.